Please Wait.....
Report
NA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 208 Pages I Data Bridge Market Research
North America colorectal cancer diagnostics market is projected to register a substantial CAGR of 8.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
North America Colorectal Cancer Diagnostics, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Some of the factors that can affect the growth of the market are:
- Rising preference for preventive health check-ups
- Rising healthcare expenditure
Market Players:
The key market players in North America colorectal cancer diagnostics market are listed below:
- F. Hoffmann-La Roche Ltd
- Koninklijke Philips N.V.
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Quest Diagnostics Incorporated
- CANON MEDICAL SYSTEMS CORPORATION.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- FUJIFILM Corporation
- Agilent Technologies, Inc.
- BD
- Siemens Healthcare GmbH
- Neusoft Corporation
- BioFire Diagnostics
- Myriad Genetics Inc.
- QIAGEN
- Hologic, Inc.
- Time Medical Holding.
- FONAR Corp.
- PlexBio
- MinFound Medical Systems Co., Ltd
- FONAR, Corp.
TABLE OF CONTENTS
1 INTRODUCTION 43
1.1 OBJECTIVES OF THE STUDY 43
1.2 MARKET DEFINITION 43
1.3 OVERVIEW OF THE NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET 43
1.4 LIMITATIONS 45
1.5 MARKETS COVERED 45
2 MARKET SEGMENTATION 48
2.1 MARKETS COVERED 48
2.2 GEOGRAPHICAL SCOPE 49
2.3 YEARS CONSIDERED FOR THE STUDY 50
2.4 CURRENCY AND PRICING 50
2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT TYPE LIFELINE CURVE 54
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
2.9 DBMR MARKET POSITION GRID 56
2.10 MARKET END USER COVERAGE GRID 57
2.11 VENDOR SHARE ANALYSIS 58
2.12 SECONDARY SOURCES 59
2.13 ASSUMPTIONS 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 63
4.1 PORTER'S FIVE FORCES 64
4.2 PESTEL ANALYSIS 65
5 INDUSTRY INSIGHTS: 66
6 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 67
6.1 REGULATORY SCENARIO IN THE U.S 67
6.2 REGULATORY SCENARIO IN AUSTRALIA 67
6.3 REGULATORY SCENARIO IN JAPAN 68
6.4 REGULATORY SCENARIO IN CHINA 68
7 MARKET OVERVIEW 70
7.1 DRIVERS 72
7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 72
7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 72
7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 72
7.2 RESTRAINTS 73
7.2.1 STRINGENT REGULATORY POLICIES 73
7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 73
7.3 OPPORTUNITIES 74
7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 74
7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 75
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 75
7.4 CHALLENGES 76
7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 76
7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 77
8 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 78
8.1 OVERVIEW 79
8.2 INSTRUMENTS 82
8.2.1 PATHOLOGY-BASED INSTRUMENTS 83
8.2.1.1 PCR INSTRUMENTS 83
8.2.1.2 SLIDE STAINING SYSTEMS 83
8.2.1.3 TISSUE PROCESSING SYSTEMS 84
8.2.1.4 CELL PROCESSORS 84
8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 84
8.2.2 IMAGING INSTRUMENTS 84
8.2.2.1 ULTRASOUND SYSTEMS 84
8.2.2.2 CT SYSTEMS 84
8.2.2.3 MRI SYSTEMS 85
8.2.2.4 OTHERS 85
8.2.3 BIOPSY INSTRUMENTS 85
8.2.4 OTHERS 85
8.3 CONSUMABLES & ACCESSORIES 85
8.3.1 KITS 86
8.3.1.1 PCR KITS 86
8.3.1.2 DNA POLYMERASE KITS 86
8.3.1.3 NUCLEIC ACID ISOLATION KITS 86
8.3.1.4 OTHERS 87
8.3.2 REAGENTS 87
8.3.2.1 ASSAYS 87
8.3.2.2 BUFFERS 87
8.3.2.3 PRIMERS 87
8.3.2.4 OTHERS 87
8.3.3 OTHER CONSUMABLES 87
9 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 88
9.1 OVERVIEW 89
9.2 STOOL EXAMINATION 92
9.3 BLOOD TEST 92
9.3.1 COMPLETE BLOOD COUNT (CBC) 93
9.3.2 TUMOR MARKER TEST 94
9.3.3 LIVER ENZYME BLOOD TEST 94
9.4 IMAGING TEST 94
9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 95
9.4.2 MRI 95
9.4.3 ULTRASOUND 95
9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 96
9.4.5 OTHERS 96
9.5 TUMOR MARKERS 96
9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 97
9.5.2 CA19-9 BIOMARKER TEST 97
9.5.3 CA 50 MARKER TEST 97
9.5.4 OTHERS 97
9.6 BIOPSY 97
9.7 OTHERS 98
10 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 99
10.1 OVERVIEW 100
10.2 STAGE III 103
10.3 STAGE IV 103
10.4 STAGE II 104
10.5 STAGE I 105
10.6 STAGE 0 105
11 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 107
11.1 OVERVIEW 108
11.2 GERIATRIC 111
11.3 ADULTS 111
11.4 PEDIATRIC 112
12 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 114
12.1 OVERVIEW 115
12.2 ADENOCARCINOMA 118
12.3 COLORECTAL LYMPHOMA 118
12.4 GASTROINTESTINAL STROMAL TUMORS 119
12.5 CARCINOID TUMORS 120
12.6 OTHERS 120
13 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 122
13.1 OVERVIEW 123
13.2 HOSPITALS 126
13.3 DIAGNOSTIC CENTERS 126
13.4 CANCER RESEARCH CENTERS 127
13.5 AMBULATORY SURGICAL CENTERS 128
13.6 ACADEMIC INSTITUTES 128
13.7 OTHERS 129
14 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 131
14.1 NORTH AMERICA 132
14.1.1 U.S. 141
14.1.2 CANADA 146
14.1.3 MEXICO 151
15 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 156
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 156
16 SWOT ANALYSIS 157
17 COMPANY PROFILE 158
17.1 F. HOFFMANN- LA ROCHE LTD 158
17.1.1 COMPANY SNAPSHOT 158
17.1.2 REVENUE ANALYSIS 158
17.1.3 COMPANY SHARE ANALYSIS 159
17.1.4 PRODUCT PORTFOLIO 159
17.1.5 RECENT DEVELOPMENT 159
17.2 KONINKLIJKE PHILIPS N.V. 160
17.2.1 COMPANY SNAPSHOT 160
17.2.2 REVENUE ANALYSIS 160
17.2.3 COMPANY SHARE ANALYSIS 161
17.2.4 PRODUCT PORTFOLIO 161
17.2.5 RECENT DEVELOPMENT 161
17.3 THERMO FISHER SCIENTIFIC INC. 163
17.3.1 COMPANY SNAPSHOT 163
17.3.2 REVENUE ANALYSIS 163
17.3.3 COMPANY SHARE ANALYSIS 164
17.3.4 PRODUCT PORTFOLIO 164
17.3.5 RECENT DEVELOPMENT 164
17.4 ILLUMINA, INC. 165
17.4.1 COMPANY SNAPSHOT 165
17.4.2 REVENUE ANALYSIS 165
17.4.3 COMPANY SHARE ANALYSIS 166
17.4.4 PRODUCT PORTFOLIO 166
17.4.5 RECENT DEVELOPMENT 166
17.5 QUEST DIAGNOSTICS INCORPORATED 167
17.5.1 COMPANY SNAPSHOT 167
17.5.2 REVENUE ANALYSIS 167
17.5.3 COMPANY SHARE ANALYSIS 168
17.5.4 PRODUCT PORTFOLIO 168
17.5.5 RECENT DEVELOPMENT 168
17.6 ABBOTT 169
17.6.1 COMPANY SNAPSHOT 169
17.6.2 REVENUE ANALYSIS 169
17.6.3 PRODUCT PORTFOLIO 170
17.6.4 RECENT DEVELOPMENT 170
17.7 AGILENT TECHNOLOGIES, INC. 171
17.7.1 COMPANY SNAPSHOT 171
17.7.2 REVENUE ANALYSIS 171
17.7.3 PRODUCT PORTFOLIO 172
17.7.4 RECENT DEVELOPMENT 172
17.8 BD 173
17.8.1 COMPANY SNAPSHOT 173
17.8.2 REVENUE ANALYSIS 173
17.8.3 PRODUCT PORTFOLIO 174
17.8.4 RECENT DEVELOPMENT 174
17.9 BEIJING O&D BIOTECH CO., LTD. 175
17.9.1 COMPANY SNAPSHOT 175
17.9.2 PRODUCT PORTFOLIO 175
17.9.3 RECENT DEVELOPMENT 175
17.10 BIOFIRE DIAGNOSTICS 176
17.10.1 COMPANY SNAPSHOT 176
17.10.2 REVENUE ANALYSIS 176
17.10.3 PRODUCT PORTFOLIO 177
17.10.4 RECENT DEVELOPMENT 177
17.11 BIO-RAD LABORATORIES, INC. 178
17.11.1 COMPANY SNAPSHOT 178
17.11.2 REVENUE ANALYSIS 178
17.11.3 PRODUCT PORTFOLIO 179
17.11.4 RECENT DEVELOPMENT 179
17.12 CANON MEDICAL SYSTEMS CORPORATION. 180
17.12.1 COMPANY SNAPSHOT 180
17.12.2 REVENUE ANALYSIS 180
17.12.3 PRODUCT PORTFOLIO 181
17.12.4 RECENT DEVELOPMENT 181
17.13 FONAR CORP. 182
17.13.1 COMPANY SNAPSHOT 182
17.13.2 REVENUE ANALYSIS 182
17.13.3 PRODUCT PORTFOLIO 183
17.13.4 RECENT DEVELOPMENT 183
17.14 FUJIFILM CORPORATION 184
17.14.1 COMPANY SNAPSHOT 184
17.14.2 REVENUE ANALYSIS 184
17.14.3 PRODUCT PORTFOLIO 185
17.14.4 RECENT DEVELOPMENT 185
17.15 GE HEALTHCARE. 186
17.15.1 COMPANY SNAPSHOT 186
17.15.2 REVENUE ANALYSIS 186
17.15.3 PRODUCT PORTFOLIO 187
17.15.4 RECENT DEVELOPMENT 187
17.16 HOLOGIC, INC. 188
17.16.1 COMPANY SNAPSHOT 188
17.16.2 REVENUE ANALYSIS 188
17.16.3 PRODUCT PORTFOLIO 189
17.16.4 RECENT DEVELOPMENT 189
17.17 MEDONICA CO. LTD 190
17.17.1 COMPANY SNAPSHOT 190
17.17.2 PRODUCT PORTFOLIO 190
17.17.3 RECENT DEVELOPMENT 190
17.18 MERCK KGAA 191
17.18.1 COMPANY SNAPSHOT 191
17.18.2 REVENUE ANALYSIS 191
17.18.3 PRODUCT PORTFOLIO 192
17.18.4 RECENT DEVELOPMENT 192
17.19 MINFOUND MEDICAL SYSTEMS CO., LTD 193
17.19.1 COMPANY SNAPSHOT 193
17.19.2 PRODUCT PORTFOLIO 193
17.19.3 RECENT DEVELOPMENT 193
17.20 MYRIAD GENETICS, INC. 194
17.20.1 COMPANY SNAPSHOT 194
17.20.2 REVENUE ANALYSIS 194
17.20.3 PRODUCT PORTFOLIO 195
17.20.4 RECENT DEVELOPMENT 195
17.21 NEUSOFT CORPORATION 196
17.21.1 COMPANY SNAPSHOT 196
17.21.2 REVENUE ANALYSIS 196
17.21.3 PRODUCT PORTFOLIO 197
17.21.4 RECENT DEVELOPMENT 197
17.22 PLEXBIO 198
17.22.1 COMPANY SNAPSHOT 198
17.22.2 PRODUCT PORTFOLIO 198
17.22.3 RECENT DEVELOPMENT 198
17.23 QIAGEN 199
17.23.1 COMPANY SNAPSHOT 199
17.23.2 REVENUE ANALYSIS 199
17.23.3 PRODUCT PORTFOLIO 200
17.23.4 RECENT DEVELOPMENT 200
17.24 SIEMENS HEALTHCARE GMBH 201
17.24.1 COMPANY SNAPSHOT 201
17.24.2 REVENUE ANALYSIS 201
17.24.3 1.2.3 PRODUCT PORTFOLIO 202
17.24.4 RECENT DEVELOPMENT 202
17.25 STERNMED GMBH 203
17.25.1 COMPANY SNAPSHOT 203
17.25.2 PRODUCT PORTFOLIO 203
17.25.3 RECENT DEVELOPMENT 203
17.26 TIME MEDICAL HOLDING. 204
17.26.1 COMPANY SNAPSHOT 204
17.26.2 PRODUCT PORTFOLIO 204
17.26.3 RECENT DEVELOPMENT 204
18 QUESTIONNAIRE 205
19 RELATED REPORTS 208
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security